Use of pharmacological agents in elucidating the mechanism of insulin action.
Srivastava
A K
AK
Department of Medicine, University of Montreal, Québec, Canada.
D000818:Animals; D017871:Calcium-Calmodulin-Dependent Protein Kinases / Q000037:antagonists & inhibitors / Q000235:genetics; D015853:Cysteine Proteinase Inhibitors / Q000494:pharmacology; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D007328:Insulin / Q000494:pharmacology*; D007329:Insulin Antagonists / Q000494:pharmacology*; D000081082:Phosphoinositide-3 Kinase Inhibitors; D047428:Protein Kinase Inhibitors; D011972:Receptor, Insulin / Q000037:antagonists & inhibitors*; D015398:Signal Transduction / Q000187:drug effects; D014158:Transcription, Genetic / Q000187:drug effects
D015853:Cysteine Proteinase Inhibitors; D007004:Hypoglycemic Agents; D007328:Insulin; D007329:Insulin Antagonists; D000081082:Phosphoinositide-3 Kinase Inhibitors; D047428:Protein Kinase Inhibitors; D011972:Receptor, Insulin; D017871:Calcium-Calmodulin-Dependent Protein Kinases